Lifeboat Foundation

DDW Editor Reece Armstrong speaks to Ellie Mahjubi, Vice President, Protein and cell analysis at Thermo Fisher Scientific, about how spatial biology is impacting drug discovery and development research.

RA: What’s the future and potential for spatial biology?

EM: Technological advancements in spatial biology are providing unprecedented insights into single cells within their spatial context, facilitating the analysis of cell types, functional states, cell interaction networks, as well as tissue microenvironments and architecture. These innovations promise to significantly advance basic research and enhance our understanding of human health and disease.

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

The authors at King’s College London say that using the radiotracer—an injected compound used in PET scans—could help inform doctors that a patient’s aggressive cancer will not respond to chemotherapy before treatment is given. This would prevent patients receiving unnecessary treatment and provide them with alternative options that will give them the best chance of beating the disease.

The paper, “Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography” published in Nature Communications, shows therapy-resistant non-small cell lung cancer tumors “lit up like a Christmas tree” on PET scans when the radiotracer was injected.

If humans want to survive long-term — millions of years into the future and beyond — we will have to grapple with existential threats to civilization and life itself. But we are more empowered than any species in history. This film is a journey far into the future to explore the extreme challenges we will face, and a vision into how far humanity might go to reinvent our planet.

Coming Spring 2025.

TSMC has revealed additional details about its “2nm N2” technology, disclosing massive advancements in yield rates and performance metrics.

TSMC’s “N2 Nanosheet” Implementation Has Brought A Huge Rise In Node Performance, Showing Immense Potential

The Taiwan giant’s 2nm process is one of the most anticipated developments in the market, mainly since the node is expected to bring in gigantic leaps in performance and efficiency results. The process is likely to come under mass production by H2 2025, and we now have information about the performance of 2nm when stacked against previous-gen counterparts, credit to the Taiwan giant’s briefing at the IEEE International Electron Device Meeting (IEDM) in San Francisco, where 2nm “nanosheets” were the highlight of the briefing.

Sign up for the Morning Brief email newsletter to get weekday updates from The Weather Channel and our meteorologists.

A powerful earthquake, possibly the strongest in years, has devastated the island nation of Vanuatu, killing at least 14 people. More than 200 are reported injured according to a post on X by Katie Greenwood, Fiji-based head of the Red Cross in the Pacific.

The 7.3-magnitude jolt rocked the region on Tuesday sending tremors through homes, businesses and critical infrastructure. Witnesses described buildings collapsing, roads blocked by landslides and hospitals stretched thin as reports of injuries — and unconfirmed casualties — surfaced.

NASA briefing on lunar lander from Firefly.

NASA holds a virtual audio-only media teleconference to highlight the NASA science flying onboard Firefly Aerospace’s Blue Ghost Mission 1 as part of the agency’s CLPS (Commercial Lunar Payload Services) initiative and Artemis campaign. Participants include:

Continue reading “Media Briefing: What’s On Board Firefly’s Blue Ghost Mission 1” »

Dr. Ethell’s groundbreaking research serves as the foundation for Leucadia Therapeutics’ work. A PhD in Neuroscience, he has studied Alzheimer’s disease for 20 years. He was a Human Frontiers of Science Long-term Fellow at the Max Planck Institute for Psychiatry in Germany and a Research Associate at the Scripps Research Institute in La Jolla, California. Dr. Ethell ran Alzheimer’s disease research at the La Jolla Institute for Immunology, served on the faculty at the University of California Riverside, and later founded the Molecular Neurobiology Group at the Western University of Health Sciences in Pomona, California, where he also chaired the Department of Neuroscience. He has authored more than 85 papers and presentations.

The Coalition for Radical Life Extension and Longevity Escape Velocity Foundation are bringing together the best in longevity research with the best in anti-aging and age-reversal practices.
The critical research Aubrey de Grey Ph.D. has curated through his renowned Longevity Summit will now be featured at RAADfest, alongside the most advanced and relevant clinical practices for impacting longevity today. RAADfest is the largest and most immersive event in the world focused on super-longevity for a general audience.

Continue reading “Reversing Brain Aging and Alzheimer’s Disease | Dr. Doug Ethell at RAADfest” »

The technique uses liquid metal to build nanoscale and microscale electronics.

Chris McHenry is Vice President of Product Management at Aviatrix.

Enterprise reliance on cloud computing is no longer a question of “if” but “how much” and “how secure.” The cloud has become the backbone of modern business, enabling rapid scaling, seamless integration and global reach.

However, as cloud adoption matures, so do its associated costs—driven significantly by the rise of artificial intelligence (AI) and the escalating energy demands of data centers. For instance, OpenAI recently revealed plans to increase its prices by 120% over the next five years, even after securing an industry-record $6.6 billion in funding.